Strain of lactic acid bacterium and edible compositions,...

Details Strain of lactic acid bacterium and edible compositions,... Strain of lactic acid bacterium and edible compositions,...

2007-05-29

2007-05-29

Afremova, Vera (Department: 1657)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C435S252100, C435S885000, C424S093440, C424S093400

Reexamination Certificate

active

10491885

ABSTRACT:
Describes a new strain ofStreptococcus thermophilusssp.salivarius(deposited on 4 Dec. 2001 at the DSMZ—Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany, with accession No. DSM 14667) and edible compositions, drugs and veterinary products containing it. The use of the said strain is particularly effective in the prevention/treatment of hepatic steatosis (fatty liver) and in nonalcoholic hepatic steatosis.

REFERENCES:
patent: 5716615 (1998-02-01), Cavaliere Vesely et al.
patent: 5760010 (1998-06-01), Klein
patent: 6225104 (2001-05-01), Cavaliere Vesely et al.
patent: 6297229 (2001-10-01), Lindor
patent: 99 29330 (1999-06-01), None
patent: WO 99/42568 (1999-08-01), None
Marshall et al, “Fermentation of milk byStreptococcus salivariussubspeciesSalivariusandStreptococcus salivariussubspeciesThermophilusand their use to the yoghurt manufacturer”, Journal of Applied Bacteriology, 1985, 59, 147-151; XP009009568.
Sheth Sunil G et al: “Nonalcoholic steatohepatitis.” Annals of Internal Medicine, vol. 126, No. 2, 1997, pp. 137-145, XP009006803 ISSN:0003-4819 cited in the application.
O'Conner B J et al: “Nonalcoholic fatty liver (NASH syndrome).” The Gastroenterologist. United States Dec. 1997, vol. 5, No. 4, Dec. 1997, pp. 316-329, XP009009572 ISSN: 1065-2477.
Oneta Carl M et al: “Non-alcoholic fatty liver disease: Treatment options based on pathogenic considerations.” Swiss Medical Weekly, vol. 132, No. 35-36, Sep. 7, 2002, pp. 493-505, XP009009570 ISSN: 1424-7860.
Hookman Perry et al: “Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach.” The American Journal of Gastroenterology. United States Feb. 2003, vol. 98, No. 2, Feb. 2003, pp. 495-499, XP009009569 ISSN: 0002-9270.
Maher J: “The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatopepatitis.” Hepatology (Baltimore, MD) United States Jan. 2001, vol. 33, No. 1, Jan. 2001, pp. 311-312, XP009009574 ISSN: 0270-9139.
Sahai Atul et al: “Upregulation of an Inflammatory Cytokine Osteopntin Precedes Steatohepatitis in a Mouse Model of NASH.” Hepatology, vol. 36, No. 4 Part 2, Oct. 2002, p. 405 A XP009009575 53RDAnnual Meeting on the Liver; Boston, MA, USA; Nov. 1-5, 2002, http://hepatology.assldjournals.org/scripts/om.dll/serve?action=searchdb&searchdbfor=home&id=jhep Oct. 2002 ISSN: 0270-9139.

Affiliated with

Also associated with

Rating

Strain of lactic acid bacterium and edible compositions,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Strain of lactic acid bacterium and edible compositions,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Strain of lactic acid bacterium and edible compositions,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3779359